Merck today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for RECARBRIO™ (imipenem, cilastatin, and relebactam) to treat...
The Los Angeles County Health Department (LAC DPH) has identified 2 cases of Enterobacter cloacae bloodstream infections in persons who received non-FDA approved stem cell injections, prompting the issuance...
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.